Olivier Brandicourt Bei Gene, Ltd. (BGNE) insider trading activity

Olivier Brandicourt is Director of BeiGene, Ltd.. Currently has a direct ownership of 27,326 shares of BGNE, which is worth approximately $6.2 Million. The most recent transaction as insider was on May 21, 2025, when has been sold 10,985 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.3K

67.22% 3M change

67.22% 12M change

Total Value Held $6.2 Million

OLIVIER BRANDICOURT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 21 2025	BUY Grant, award, or other acquisition	-	10,985 Added 28.67%	27,326 Ordinary Shares
Jun 05 2024	BUY Grant, award, or other acquisition	-	16,341 Added 50.0%	16,341 Ordinary Shares

Also insider at

ALNY

ALNYLAM PHARMACEUTICALS, INC. Healthcare

Director

PCVX

Vaxcyte, Inc. Healthcare

Director